SLC3A2 and systemic lupus erythematosus: Enriched populations of CD98− NDN, CD98− LDN and CD98+ LDN from the PB of SLE patients were isolated and the ability to produce IL‐6 in response to LPS was assessed using ELISpot (Figure 7A–C).